PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22057509-5	2011	The patient underwent one course of idarubicin and cytosine arabinose therapy combined with imatinib followed by daunorubicin/cyclophosphamide plus vincristine and prednisone/L: -asparaginase (DNR/COP/L: -ASP) therapy, high-dose cytosine arabinose, and CHOP therapy (cyclophosphamide, doxorubicin, vincristine, and prednisolone).	Idarubicin	36-46	DNA damage inducible transcript 3	Homo sapiens	253-257	
9669685-0	1998	Etoposide and idarubicin in a modified CHOP-like regimen (VICED) for aggressive non-Hodgkin"s lymphomas.	Idarubicin	14-24	DNA damage inducible transcript 3	Homo sapiens	39-43